Fda Invest Information

Pharmaceuticals
SciSparc Granted FDA Approval for Phase IIb Trial of Novel Tourette Syndrome Therapy Oct 1, 2024
Pharmaceuticals
FDA Removes Clinical Hold on BMF-219 Trials for Diabetes by Biomea Fusion Sep 27, 2024
Stocks
InspireMD Seeks FDA Approval for CGuard Prime EPS Amidst Stock Volatility Sep 18, 2024
Pharmaceuticals
Johnson & Johnson Targets FDA Approval for Groundbreaking gMG Drug Amidst Fierce Competition Aug 30, 2024
Companies
Inspire Medical Systems Achieves FDA Approval for Pioneering Inspire V Therapy System Aug 6, 2024
Companies
FDA Grants Anixa Biosciences' Individual Patient IND for Second Dose of CAR-T Ovarian Cancer Therapy Jul 23, 2024
Pharmaceuticals
FDA Grants Approval to Arcutis' Novel ZORYVE® Cream for Atopic Dermatitis Patients Jul 10, 2024
Companies
FDA Approves Lilly's Kisunla™ for Early Symptomatic Alzheimer's Jul 3, 2024
Pharmaceuticals
FDA Grants Accelerated Approval to Ipsen and Genfit's Iqirvo for Liver Disease Treatment Jun 12, 2024
Pharmaceuticals
GENFIT Reaches Historic FDA Approval with Ipsen's Iqirvo® for Primary Biliary Cholangitis Jun 11, 2024
Companies
Eisai Submits LEQEMBI® (lecanemab-irmb) Biologics License Update to FDA for Early Alzheimer's Treatment – Biogen Stocks in Focus Jun 10, 2024
Pharmaceuticals
Sobi's Emapalumab-lzsg Granted FDA Fast Track Designation for Macrophage Activation Syndrome May 25, 2024
Pharmaceuticals
Sanofi’s Dupixent Under FDA Priority Review for Adolescents with CRSwNP May 14, 2024
Companies
Meta Platforms, Inc. Under Investigation by U.S. Prosecutors for Alleged Role in Illicit Drug Sales Mar 16, 2024
Stocks
Quoin Pharmaceuticals Gains FDA Approval to Include Teens in Netherton Syndrome Studies, Boosting QNRX Shares Mar 5, 2024
Pharmaceuticals
SpringWorks Therapeutics Begins Rolling NDA Submission for NF1-PN Treatment Mar 5, 2024
Companies
Intelligent Bio Solutions Forges Strategic Alliance with Cliantha Research for Vital FDA 510(k) Clinical Study Feb 28, 2024
Pharmaceuticals
FDA Approves Asthma Drug Xolair for Treating Severe Food Allergies Feb 17, 2024
Companies
Inhibikase Therapeutics Reports Preliminary FDA Meeting Outcomes for IkT-001Pro Feb 8, 2024
Companies
Inhibikase Therapeutics Provides Update on FDA Pre-NDA Meeting for Cancer Treatment Feb 8, 2024
Stocks
Coherus BioSciences and Ascent Industries Highlight Stocks to Watch as Market Futures Dip Dec 28, 2023
Markets
ReShape Lifesciences Soars on FDA Approval, Premarket Stock Movements Observed Across Various Sectors Dec 14, 2023
Biotechnology
Sernova Granted FDA Orphan Drug and Rare Pediatric Disease Designations for Hemophilia A Treatment Nov 28, 2023
Companies
FDA Greenlights Immix Biopharma's IND for CAR-T Therapy NXC-201, Paving the Way for US Clinical Trials Nov 21, 2023
Companies
Agilent (A) Secures FDA Nod for PD-L1 IHC 22C3, Aiding Cancer Treatment Nov 16, 2023
Investment
SciSparc Ltd. Embarks on Transformative Phase IIb Trial for Tourette Syndrome Using THC-Based Medication Nov 11, 2023
Pharmaceuticals
FDA Approves Ixchiq: First Vaccine for Chikungunya Virus by Valneva Nov 10, 2023
Companies
The daily business briefing: November 9, 2023 Nov 10, 2023
Stocks
Valneva SE's VALN Chikungunya Vaccine Receives FDA Approval, Company's Stock Rises Nov 10, 2023
GH Research Advances Clinical Trials for GH001 in the Fight Against Treatment-Resistant Depression Nov 9, 2023